Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.

Biotechnology

Health & Wellness

Annexon Biosciences

Annexon Biosciences' headquarters in South San Francisco, CA, United States

This department conducts scientific investigations and analysis to advance knowledge and innovation.

Research Department

The Clinical Development and Operations team at Annexon Biosciences is responsible for designing and executing clinical trials to evaluate the safety and efficacy of their innovative complement medicines. This team collaborates across various functions, including regulatory affairs, data management, and biostatistics, to ensure that all clinical programs are conducted according to regulatory standards and timelines, ultimately aiming to bring groundbreaking therapies to patients with severe autoimmune and neurodegenerative disorders.

Clinical Development and Operations

This department is responsible for overseeing clinical trials, ensuring regulatory compliance, and managing drug safety and biomarker activities.

Clinical Operations and Safety

This department oversees the company's governance structures, ensuring compliance and accountability at the highest levels.

Corporate Governance

This department provides expert guidance and support in scientific matters and research initiatives.

Scientific Services

This department engages with healthcare professionals to provide medical information and support related to products and therapies.

Field Medical Affairs

The Leadership Team at Annexon Biosciences is responsible for setting the strategic direction and overarching vision of the company. This collaborative group, which includes executives overseeing critical areas such as finance, business development, and innovation, drives the advancement of Annexon’s complement medicines and ensures alignment with the company’s mission to address autoimmune, neurodegenerative, and ophthalmic disorders. They also foster partnerships and collaborations to enhance research and development efforts, ultimately aiming to bring transformative treatments to patients.

��

People (4)

Jobs (0)

Other teams

Clinical Development and Operations

Clinical Operations and Safety

Corporate Governance

Scientific Services

Field Medical Affairs

Leadership Team

��������

People (4)

Jobs (0)

Other teams

Clinical Development and Operations

Clinical Operations and Safety

Corporate Governance

Scientific Services

Field Medical Affairs

Leadership Team

��